Manila Bulletin
Solons urge FDA to cut red tape, expedite procedures for local drug manufacturers
House Speaker Lord Allan Velasco urged the Philippine Food and Drug Administration (FDA) to streamline its processes for local drug producers seeking permits.
Velasco emphasized the critical role of local pharmaceutical companies in supplying essential COVID-19 medicines during the pandemic.
He highlighted the need to balance thorough drug evaluation with reduced bureaucratic hurdles for local firms.
Reports indicate that numerous products from local manufacturers have faced prolonged delays in regulatory approval.
House Deputy Speaker Bernadette Herrera-Dy supported Velasco's call, noting the difficulty in accessing newly available COVID-19 therapies due to slow FDA processing.
Herrera-Dy stated that local manufacturers are prepared to produce these medicines, but FDA approval timelines hinder their availability.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Anti-Red Tape Authority (ARTA) is expediting permit applications for potential COVID-19 vaccine manufacturers in the Philippines by establishing a 'green lane' for faster processing.
Read more →
President Rodrigo Duterte has approved the Department of Trade and Industry's (DTI) request to provide assistance to potential local vaccine manufacturers in the Philippines.
Read more →